Cargando…
Luteolin Attenuates Cardiac Ischemia/Reperfusion Injury in Diabetic Rats by Modulating Nrf2 Antioxidative Function
Luteolin has been reported to attenuate ischemia/reperfusion (I/R) injury in the diabetic heart through endothelial nitric oxide synthase- (eNOS-) related antioxidative response. Though the nuclear factor erythroid 2-related factor 2 (Nrf2) is regarded as a key endogenous factor to reduce diabetic o...
Autores principales: | Xiao, Chi, Xia, Man-Li, Wang, Jue, Zhou, Xin-Ru, Lou, Yang-Yun, Tang, Li-Hui, Zhang, Feng-Jiang, Yang, Jin-Ting, Qian, Ling-Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476158/ https://www.ncbi.nlm.nih.gov/pubmed/31089405 http://dx.doi.org/10.1155/2019/2719252 |
Ejemplares similares
-
The Antioxidant Transcription Factor Nrf2 in Cardiac Ischemia–Reperfusion Injury
por: Mata, Ana, et al.
Publicado: (2021) -
Luteolin modulates SERCA2a via Sp1 upregulation to attenuate myocardial ischemia/reperfusion injury in mice
por: Hu, Ya, et al.
Publicado: (2020) -
Luteolin Limits Infarct Size and Improves Cardiac Function after Myocardium Ischemia/Reperfusion Injury in Diabetic Rats
por: Sun, Dongdong, et al.
Publicado: (2012) -
Luteolin Treatment Protects against Renal Ischemia-Reperfusion Injury in Rats
por: Hong, Xin, et al.
Publicado: (2017) -
Pharmacodynamic Effect of Luteolin Micelles on Alleviating Cerebral Ischemia Reperfusion Injury
por: Tan, Liwei, et al.
Publicado: (2018)